Program Agenda

June 16 – 18, 2013

pdf_icon  Downloadable Agenda

Sunday, June 16
MIT Faculty Club, 50 Memorial Drive, Building E52, 6th Floor, Cambridge, MA
5:30 – 6:30 Registration and cocktails
6:30 – 8:30 Welcome Dinner
Welcome Remarks
Dean David Schmittlein, MIT Sloan School of Management

Opportunities and Challenges in Cancer Drug Development
Anna Protopapas, Millennium: The Takeda Oncology Company

Monday, June 17
Wong Auditorium, 70 Memorial Drive, Building E51, Cambridge, MA (entrance at corner of Wadsworth and Amherst Streets)
8:00 – 8:30 Continental Breakfast
8:30 – 9:15 Welcome
Daniel Goroff, Alfred P. Sloan Foundation; Thomas Kalil, White House Office of Science and Technology Policy; J. Leonard Lichtenfeld, American Cancer Society; Larry Nagahara, NCI
9:15 – 10:00 Background, and Conference Objectives
Andrew W. Lo, MIT
10:00 – 10:15 Break
10:15 – 12:15 Session 1: Scientific and Engineering Challenges
Parag Mallick*, Stanford and Nicholas F. Marko*, MD Anderson
Lewis C. Cantley, Weill Cornell and Agios; Larry Norton, Memorial Sloan-Kettering; Phillip A. Sharp, MIT; Thomas Unger, Pfizer
12:30 – 2:30 Lunch and Speaker: Robert A. Weinberg, Whitehead Institute
2:30 – 4:00 Session 2: New Business Models A
Gary Pisano*, Harvard Business School
Jim Broderick, Morgenthaler Ventures; Gigi Hirsch, MIT NEWDIGS; Fiona Murray, MIT; J. Marty Tenenbaum, CancerCommons
4:00 – 4:30 Break
4:30 – 6:00 Session 3: Financing Structure, Marketing, and Investor Perspectives
Douglas A. Dachille*, First Principles Capital Management
Britt Canady, Bank of America Merrill Lynch; Michael Fusco, Morgan Stanley
Peter Hancock, AIG; Kira Rosoff, Deutsche Bank
6:00 – 6:30 Day 1 Conference Wrap-Up
6:30 – 8:30 Dinner
Location: MIT Media Lab, 75 Amherst Street, 6th Floor, Building E14, Cambridge, MA

Tuesday, June 18
Wong Auditorium, 70 Memorial Drive, Building E51, Cambridge, MA (entrance at corner of Wadsworth and Amherst Streets)
8:00 – 9:00 Continental Breakfast
9:00 – 10:30 Session 4: Government, Healthcare Reform, and Non-Profits
Clifford Gibbons*, Gibbons & Co.
Douglas Criscitello, Grant Thornton; Ora Dar, Israeli Life Sciences Fund; Jonathan Gruber, MIT; Robert O’Neill, FDA; John S. Parker, SAIC
10:30 – 11:00 Break
11:00 – 12:30 Session 5: New Business Models B
Andrew W. Lo*, MIT
Edward Benz, Dana-Farber Cancer Institute; Ansbert Gadicke, MPM Capital; Frank McCormick, UCSF; John McKew, National Institutes of Health, NCATS, TRND; Alastair Wood, Symphony Capital LLC
12:30 – 2:00 Lunch and Speaker: Robert Langer, MIT
2:00 – 3:30 Session 6: Technology Licensing and Intellectual Property Issues
Lita Nelsen*
, MIT TLO and O. Prem Das*, Dana Farber TLO
Jeb Keiper, GlaxoSmithKline; Vikas P. Sukhatme, Beth Israel Deaconess Medical Center; Teri Willey, Mount Sinai Medical Center
3:30 – 3:45 Break
3:45 – 5:15 Session 7: Credit Models and Debt Ratings
Roger Stein*
, Moody’s and MIT LFE
John Hull, UToronto; Bruce N. Lehmann, UCSD; Robert C. Merton, MIT; Henry Shilling, Moody’s Investor Services; Chip Wallach, Bank of America Merrill Lynch
5:15 – 6:00 Day 2 Conference Wrap-Up
* Moderator and Session Chair